A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis

NCT ID: NCT06280716

This clinical trial is studying a medication called lebrikizumab to see how well it works in treating moderate-to-severe atopic dermatitis, also known as eczema. The trial will last about 62 weeks ...

Recruiting

Phase: PHASE3 Conditions: Atopic Dermatitis

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

NCT ID: NCT06292013

The ACCLAIM-Lp(a) trial is studying a new treatment called lepodisiran to see if it can help reduce the risk of serious heart problems in adults who have high levels of a substance called lipoprote...

Recruiting

Phase: PHASE3 Conditions: Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

NCT ID: NCT06119581

This clinical trial is investigating whether a new drug called LY3537982, combined with standard cancer treatments like immunotherapy and chemotherapy, is more effective for patients with advanced ...

Recruiting

Phase: PHASE3 Conditions: Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults

NCT ID: NCT07083739

This clinical trial is studying a medicine called TQB3473, which comes in tablet form, to see if it is safe and helpful for adults who have a condition called primary immune thrombocytopenia (ITP)....

Not yet recruiting

Phase: PHASE2 Conditions: Primary Immune Thrombocytopenia

Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis

NCT ID: NCT06615726

This clinical trial is studying whether regular physical activity can help prevent strokes in patients who have symptoms from a narrowing of the arteries in the brain, known as symptomatic intracra...

Recruiting

Phase: PHASE3 Conditions: Ischemic Stroke, Transient Ischemic Attack

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

NCT ID: NCT06551324

This clinical trial, called MEVPRO-1, is looking at a new medicine called PF-06821497 (Mevrometostat) to see if it can help men with metastatic castrate-resistant prostate cancer (mCRPC) who have p...

Recruiting

Phase: PHASE3 Conditions: Metastatic Castrate Resistant Prostate Cancer (mCRPC)

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

NCT ID: NCT06629779

This clinical trial is studying a new drug called PF-06821497 (also known as Mevrometostat) to see if it works better when combined with another medication called enzalutamide for men with metastat...

Recruiting

Phase: PHASE3 Conditions: Metastatic Castration-Resistant Prostate Cancer

Treatment of Moderate to Severe Plaque Psoriasis

NCT ID: NCT06542614

This clinical trial is investigating a new medication called TQH3906 to see how effective and safe it is for people with moderate to severe plaque psoriasis, a skin condition that causes red, scaly...

Recruiting

Phase: PHASE2 Conditions: Plaque Psoriasis

A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer

NCT ID: NCT07043725

This clinical trial is testing a new treatment called TQB2102 for people with HER2-positive breast cancer, a type of breast cancer that grows quickly and needs specific targeted therapy. The study ...

Not yet recruiting

Phase: PHASE3 Conditions: HER2-positive Breast Cancer

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

NCT ID: NCT05100862

This clinical trial is studying two different treatment combinations for patients with certain types of lymphoma that have returned or not responded to previous treatments. The first combination be...

Recruiting

Phase: PHASE3 Conditions: Marginal Zone Lymphoma, Relapsed/Refractory Follicular Lymphoma

ICP-332 in Subjects With Non-segmental Vitiligo

NCT ID: NCT07047612

This clinical trial is studying a new medicine called ICP-332 to see if it can help people with non-segmental vitiligo, a condition where patches of skin lose their color. The study is being done i...

Recruiting

Phase: PHASE2 Conditions: Non Segmental Vitiligo

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

NCT ID: NCT04973605

This clinical trial is studying a new treatment called BGB-11417 for patients with relapsed or refractory multiple myeloma, which is a type of blood cancer. The trial has two parts: the first part ...

Recruiting

Phase: PHASE1 Conditions: Relapsed/Refractory Multiple Myeloma

Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis

NCT ID: NCT07022847

This clinical trial is exploring whether a tool called the Pleth Variability Index (PVI) can help predict low blood pressure during routine hemodialysis treatments. Low blood pressure can be a comm...

Recruiting

Conditions: Hemodialysis, Intradialytic Hypotension +2 more

A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma

NCT ID: NCT06049290

This clinical trial is studying a new treatment called LBL-034 for patients with relapsed or refractory multiple myeloma, which means their cancer has come back or hasn’t responded to other treatme...

Recruiting

Phase: PHASE1 Conditions: Relapsed/Refractory Multiple Myeloma

A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia

NCT ID: NCT06900920

This clinical trial is testing a new medication called TQB3473 tablets to see if it can help adults with a condition called Primary Immune Thrombocytopenia (ITP). ITP is a disease where the body do...

Recruiting

Phase: PHASE3 Conditions: Primary Immune Thrombocytopenia

Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort

NCT ID: NCT06963489

The Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort trial is studying how to better understand and treat a type of stroke called acute ischemic stroke with large vessel occlusion...

Recruiting

Conditions: Acute Ischemic Stroke, Large Vessel Occlusion

Efficacy of MI078 Capsules in Treating Postpartum Depression

NCT ID: NCT06963580

This clinical trial is studying a medication called MI078 capsules to see if it can help women who are experiencing postpartum depression, which is a type of depression that can occur after giving ...

Recruiting

Phase: PHASE2 Conditions: Postpartum Depression

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

NCT ID: NCT05458219

This clinical trial is studying a new medication called IBI343 to see how safe it is and how well it works for people with advanced solid tumors that cannot be surgically removed or have spread to ...

Recruiting

Phase: PHASE1 Conditions: Locally Advanced Unresectable or Metastatic Solid Tumors

Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

NCT ID: NCT06842199

This clinical trial is investigating a new treatment called ICP-488 for adults with moderate to severe plaque psoriasis, a skin condition that causes red, scaly patches. The study is taking place a...

Recruiting

Phase: PHASE3 Conditions: Plaque Psoriasis Patients

Trial of Rescue Endovascular Treatment for Progressive Acute Mild Ischemic Stroke With Basilar Artery Occlusion With Extended Time Window

NCT ID: NCT06843356

This clinical trial is looking at a new treatment approach for patients who are experiencing a specific type of stroke called acute mild ischemic stroke due to blockage in the basilar artery. The s...

Recruiting

Phase: NA Conditions: Basilar Artery Occlusion, Acute Mild Ischemic Stroke +2 more

Main Menu

Clinical Trials in Wuhu, Anhui

53 Active Trials Found in Wuhu

A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Treatment of Moderate to Severe Plaque Psoriasis

A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

ICP-332 in Subjects With Non-segmental Vitiligo

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis

A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma

A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia

Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort

Efficacy of MI078 Capsules in Treating Postpartum Depression

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

Trial of Rescue Endovascular Treatment for Progressive Acute Mild Ischemic Stroke With Basilar Artery Occlusion With Extended Time Window